Literature DB >> 10788666

Fluorescein-labeled naloxone binding to mu opioid receptors on live Chinese hamster ovary cells using confocal fluorescent microscopy.

B W Madsen1, C L Beglan, C E Spivak.   

Abstract

A general method of confocal laser scanning microscopy was used to demonstrate specific binding of fluorescein-labeled naloxone (FNAL, 10-50 nM) to stably transfected mu opioid receptors on live Chinese hamster ovary cells. Nonspecific binding was visually indistinguishable from autofluorescence in cells with intact cell membranes. Fluorescent labeling of cell perimeters, not present in control nontransfected cells, reversed in transfected cells upon washout of FNAL or following the addition of either unlabeled naloxone (25 microM) or the mu specific antagonist CTOP (1 microM). The addition of the delta and kappa specific agonists DPDPE (1 microM) and U50488 (1 microM), respectively, failed to reverse the labeling. Further evidence of specific binding was obtained from kinetic experiments, where it was observed that only transfected cells showed a time-dependent exponential change in fluorescence that permitted estimation of association and dissociation binding rate constants of (5.8+/-0.5, mean+/-S.E.M.)x10(5) M(-1) s(-1) and (3.3+/-0.6)x10(-3) s(-1), respectively and a kinetically derived dissociation constant of 5.7+/-1.4 nM. These estimates were comparable to those obtained under similar conditions in radioligand binding experiments using [3H]-naloxone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10788666     DOI: 10.1016/s0165-0270(00)00175-8

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  8 in total

1.  Do fluorescent drugs show you more than you wanted to know?

Authors:  J C McGrath; C J Daly
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 2.  Fluorescent approaches for understanding interactions of ligands with G protein coupled receptors.

Authors:  Rajashri Sridharan; Jeffrey Zuber; Sara M Connelly; Elizabeth Mathew; Mark E Dumont
Journal:  Biochim Biophys Acta       Date:  2013-09-18

3.  Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1β: evidence for opioid-immune crosstalk.

Authors:  Shekher Mohan; Randall L Davis; Udaya DeSilva; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2010-07-07       Impact factor: 3.478

Review 4.  Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).

Authors:  Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2009-04-30       Impact factor: 4.774

5.  Illuminating the life of GPCRs.

Authors:  Ilka Böhme; Annette G Beck-Sickinger
Journal:  Cell Commun Signal       Date:  2009-07-14       Impact factor: 5.712

Review 6.  Portraying G protein-coupled receptors with fluorescent ligands.

Authors:  Francisco Ciruela; Kenneth A Jacobson; Víctor Fernández-Dueñas
Journal:  ACS Chem Biol       Date:  2014-07-28       Impact factor: 5.100

7.  Investigating endogenous µ-opioid receptors in human keratinocytes as pharmacological targets using novel fluorescent ligand.

Authors:  Cheryl Leong; Christine Neumann; Srinivas Ramasamy; Bhimsen Rout; Lim Yi Wee; Mei Bigliardi-Qi; Paul L Bigliardi
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240

8.  Visualizing endogenous opioid receptors in living neurons using ligand-directed chemistry.

Authors:  Seksiri Arttamangkul; Andrew Plazek; Emily J Platt; Haihong Jin; Thomas F Murray; William T Birdsong; Kenner C Rice; David L Farrens; John T Williams
Journal:  Elife       Date:  2019-10-07       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.